Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ashish Khanna

Critical Care Medicine Winston Salem, NC Medical Doctor

NPI 1356662084 CMS profile 243457

Medical Center Blvd, Fl 9, Winston Salem, NC 27157

Open in the dashboard

General payments

$363,556

234 records reported · program years 2019–2025

Research payments

$1,850

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,634,510 paid to institutions, not to them · program years 2022–2025

Through program year 2025, Ashish Khanna of Winston Salem, NC is reported in the CMS Open Payments database as having received $363,556 across 234 general payments and $1,850 in research payments paid to them. Separately, studies naming them as principal investigator received $1,634,510 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Critical Care Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $29,293 32
2024 General $37,149 34
2024 Research $1,850 2
2023 General $29,655 33
2022 General $51,599 41
2021 General $98,007 49
2020 General $89,437 23
2019 General $28,416 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ashish Khanna
  • Critical Care Medicine median
  • Middle half of Critical Care Medicine
  • National median

In program year 2025, general payments to Ashish Khanna were reported at $29,293. Among 445 Critical Care Medicine profiles paid that year, the median was $97 and the middle half received between $33 and $255.

Show as a table
Year Ashish Khanna Critical Care Medicine median Middle half National median
2019 $28,416 $103 $29–$256 $163
2020 $89,437 $60 $22–$164 $114
2021 $98,007 $115 $30–$249 $132
2022 $51,599 $97 $27–$196 $149
2023 $29,655 $104 $31–$245 $160
2024 $37,149 $93 $28–$268 $164
2025 $29,293 $97 $33–$255 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $91,954 84 payments
  2. Edwards Lifesciences Corporation $80,974 43 payments
  3. Covidien LP $75,475 24 payments
  4. Philips Electronics North America Corporation $40,287 25 payments
  5. Trevena, Inc. $14,299 6 payments
  6. Baxter Healthcare $12,750 3 payments
  7. Potrero Medical, Inc. $11,752 9 payments
  8. Mylan Inc. $9,319 3 payments
  9. Ge Healthcare $7,217 4 payments
  10. La Jolla Pharmaceutical Company $6,477 13 payments
  11. Other $13,051 20 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $189,884 81 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $129,947 62 payments
  3. Honoraria $21,167 10 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $10,560 6 payments
  5. Travel and Lodging $5,674 12 payments
  6. Food and Beverage $4,388 60 payments
  7. Acquisitions $1,760 1 payment
  8. Education $176 2 payments
Products named General payments · program years 2019–2025
  1. Nellcor Pulse Oximetry $18,336 8 payments
  2. (8325) Respiratory $16,396 8 payments
  3. OLINVYK $14,299 6 payments
  4. GIAPREZA Low Blood Pressure $9,319 3 payments
  5. Nellcor Pulse Oximetry $9,126 11 payments
  6. BIOBUTTON $7,834 13 payments
  7. (2858) General Consulting $6,600 3 payments
  8. Respiratory $6,154 4 payments
  9. GIAPREZA Emergent Hypotension $5,974 7 payments
  10. INVOS $5,754 5 payments
  11. Other $28,185 51 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $1,850 2 payments

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$17,442

Medicare's payments for the services billed

Medicare patients

63

Average age 70

Services billed

136

23 women, 40 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 57%
Chronic kidney disease 54%
Atrial fibrillation 52%
Heart failure 48%
Arthritis 40%
Diabetes 37%
COPD 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

236 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Critical Care Medicine in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record